Brief: Theranexus Announces Issuance Of European Patent Covering Its Drug Candidate THN102 For Treatment Of Narcolepsy and Parkinson's Disease

Thx Pharma SA

11/01/2018 06:31

Jan 11 (Reuters) - THERANEXUS SA  ALTHX.PA : 
    * THERANEXUS ANNOUNCES ISSUANCE OF EUROPEAN PATENT COVERING 
ITS 
DRUG CANDIDATE THN102 FOR TREATMENT OF NARCOLEPSY AND 
PARKINSON'S DISEASE 
    * RESULTS ARE EXPECTED IN Q2 OF 2019 
    * AT END OF 2017, LAUNCHED REGULATORY ACTIVITIES REQUIRED 
TO 
START NEW PHASE II CLINICAL TRIAL FOR THN102 IN 2018 
 
Source text for Eikon:  ID:nACT51619  
Further company coverage:  ALTHX.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))